Another investigation demonstrates that levels of phosphorylated tau proteins (P-S396-tau and P-tau-181) and Aβ-42 in neurally derived blood EVs can predict the onset of AD up to 10 years before clinical symptoms emerge (Fiandaca et al., 2015). This evidence concerns the gene MAPT and Alzheimer disease.